Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells
出版年份 2023 全文链接
标题
Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells
作者
关键词
-
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 249, Issue -, Pages 115140
出版商
Elsevier BV
发表日期
2023-01-21
DOI
10.1016/j.ejmech.2023.115140
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting CDK9 for Anti-Cancer Therapeutics
- (2021) Ranadip Mandal et al. Cancers
- Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.
- (2019) Roca et al. Journal of Clinical Medicine
- Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity
- (2019) Jubo Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase1 (HDAC1) against Malignant Cancer
- (2018) Yongtao Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- What Makes a Piece of Art or Science a Masterpiece?
- (2018) Joseph L. Goldstein CELL
- Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor
- (2018) Beilei Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine
- (2018) Jieping Li et al. JOURNAL OF NANOBIOTECHNOLOGY
- Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro
- (2017) Jubo Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model
- (2017) Umed Singh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells
- (2016) Shao Xie et al. ACTA PHARMACOLOGICA SINICA
- Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy
- (2016) Yogesh A. Sonawane et al. JOURNAL OF MEDICINAL CHEMISTRY
- The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
- (2015) A. Baker et al. CANCER RESEARCH
- Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors
- (2014) Gábor Németh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
- (2014) Monique Terwijn et al. PLoS One
- Cyclin-dependent kinases
- (2014) Marcos Malumbres GENOME BIOLOGY
- Cdks, cyclins and CKIs: roles beyond cell cycle regulation
- (2013) S. Lim et al. DEVELOPMENT
- Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities
- (2013) Hao Shao et al. JOURNAL OF MEDICINAL CHEMISTRY
- A clinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
- (2012) J. M. Gerber et al. BLOOD
- Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
- (2009) Rong Chen et al. BLOOD
- Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex
- (2009) Jiayun Lu et al. PLoS One
- Identification ofN-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design†
- (2008) Paul G. Wyatt et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More